Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 USD | +1.73% | +3.01% | -40.06% |
Apr. 17 | Evaxion Announces Phase 2 Clinical Trial Update | CI |
Apr. 11 | European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.06% | 21.43M | |
-1.78% | 41.36B | |
+44.81% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |
- Stock Market
- Equities
- EVAX Stock
- News Evaxion Biotech A/S
- Evaxion Biotech Says CEO Resigns, Per Norlen Named as Replacement; Shares Drop